GIM
EWTX icon

Granahan Investment Management’s Edgewise Therapeutics EWTX Stock Holding History

Granahan Investment Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.87M Sell
193,778
-7,065
-4% -$244K 0.28% 84
2026
Q1 		$6.33M Sell
200,843
-31,452
-14% -$907K 0.31% 83
2025
Q4 		$5.76M Sell
232,295
-107,322
-32% -$2.15M 0.25% 96
2025
Q3 		$5.51M Sell
339,617
-65,861
-16% -$934K 0.23% 90
2025
Q2 		$5.32M Buy
405,478
+187,811
+86% +$2.71M 0.22% 100
2025
Q1 		$4.79M Sell
217,667
-82,346
-27% -$2.16M 0.24% 96
2024
Q4 		$8.01M Sell
300,013
-211,892
-41% -$6.75M 0.33% 77
2024
Q3 		$13.7M Sell
511,905
-198,818
-28% -$3.96M 0.54% 53
2024
Q2 		$12.8M Buy
710,723
+102,711
+17% +$1.79M 0.51% 60
2024
Q1 		$11.1M Sell
608,012
-466,896
-43% -$7.42M 0.39% 75
2023
Q4 		$11.8M Buy
1,074,908
+135,781
+14% +$953K 0.39% 77
2023
Q3 		$5.38M Buy
939,127
+294,414
+46% +$2M 0.19% 124
2023
Q2 		$5M Sell
644,713
-88,951
-12% -$750K 0.15% 133
2023
Q1 		$4.89M Buy
+733,664
New +$6.8M 0.15% 127

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Granahan Investment Management's EWTX Position: Q2 2026 in Review

Granahan Investment Management reduced its Edgewise Therapeutics (EWTX) stake by 3.5% in Q2 2026, selling an estimated $244K and leaving 193,778 shares worth $7.87M. The position accounts for 0.28% of the portfolio, ranked #84.

Granahan Investment Management first reported a position in EWTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.7M in Q3 2024. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Granahan Investment Management held 193,778 shares of Edgewise Therapeutics worth $7.87M as of Q2 2026.
  • Granahan Investment Management sold 7,065 Edgewise Therapeutics shares in Q2 2026, an estimated $244K.
  • Edgewise Therapeutics made up 0.28% of Granahan Investment Management's portfolio in Q2 2026, its #84 holding.
  • Granahan Investment Management first reported a position in Edgewise Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Granahan Investment Management's Edgewise Therapeutics position peaked at $13.7M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.